177 related articles for article (PubMed ID: 38305364)
1. Role of the leucine-rich repeat protein kinase 2 C-terminal tail in domain cross-talk.
Sharma PK; Weng JH; Manschwetus JT; Wu J; Ma W; Herberg FW; Taylor SS
Biochem J; 2024 Feb; 481(4):313-327. PubMed ID: 38305364
[TBL] [Abstract][Full Text] [Related]
2. Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order-Disorder Transition Upon Activation.
Weng JH; Trilling CR; Kaila Sharma P; Störmer E; Wu J; Herberg FW; Taylor SS
J Mol Biol; 2023 Jun; 435(12):167999. PubMed ID: 36764356
[TBL] [Abstract][Full Text] [Related]
3. PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain.
Malik AU; Karapetsas A; Nirujogi RS; Chatterjee D; Phung TK; Wightman M; Gourlay R; Morrice N; Mathea S; Knapp S; Alessi DR
Biochem J; 2022 Sep; 479(18):1941-1965. PubMed ID: 36040231
[TBL] [Abstract][Full Text] [Related]
4. LRRK2 Structure-Based Activation Mechanism and Pathogenesis.
Zhang X; Kortholt A
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189360
[TBL] [Abstract][Full Text] [Related]
5. LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains.
Weng JH; Aoto PC; Lorenz R; Wu J; Schmidt SH; Manschwetus JT; Kaila-Sharma P; Silletti S; Mathea S; Chatterjee D; Knapp S; Herberg FW; Taylor SS
PLoS Biol; 2022 Feb; 20(2):e3001427. PubMed ID: 35192607
[TBL] [Abstract][Full Text] [Related]
6. Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding.
Kalogeropulou AF; Purlyte E; Tonelli F; Lange SM; Wightman M; Prescott AR; Padmanabhan S; Sammler E; Alessi DR
Biochem J; 2022 Sep; 479(17):1759-1783. PubMed ID: 35950872
[TBL] [Abstract][Full Text] [Related]
7. Capturing the domain crosstalk in full length LRRK2 and LRRK2RCKW.
Störmer E; Weng JH; Wu J; Bertinetti D; Kaila Sharma P; Ma W; Herberg FW; Taylor S
Biochem J; 2023 May; 480(11):815-33. PubMed ID: 37212165
[TBL] [Abstract][Full Text] [Related]
8. The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation.
Cogo S; Ho FY; Tosoni E; Tomkins JE; Tessari I; Iannotta L; Montine TJ; Manzoni C; Lewis PA; Bubacco L; Chartier Harlin MC; Taymans JM; Kortholt A; Nichols J; Cendron L; Civiero L; Greggio E
Brain Res; 2022 Mar; 1778():147781. PubMed ID: 35016853
[TBL] [Abstract][Full Text] [Related]
9. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.
Jaleel M; Nichols RJ; Deak M; Campbell DG; Gillardon F; Knebel A; Alessi DR
Biochem J; 2007 Jul; 405(2):307-17. PubMed ID: 17447891
[TBL] [Abstract][Full Text] [Related]
10. Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations.
Mills RD; Mulhern TD; Cheng HC; Culvenor JG
Biochem Soc Trans; 2012 Oct; 40(5):1086-9. PubMed ID: 22988870
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the WD40 domain dimer of LRRK2.
Zhang P; Fan Y; Ru H; Wang L; Magupalli VG; Taylor SS; Alessi DR; Wu H
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1579-1584. PubMed ID: 30635421
[TBL] [Abstract][Full Text] [Related]
12. Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts.
Guaitoli G; Raimondi F; Gilsbach BK; Gómez-Llorente Y; Deyaert E; Renzi F; Li X; Schaffner A; Jagtap PK; Boldt K; von Zweydorf F; Gotthardt K; Lorimer DD; Yue Z; Burgin A; Janjic N; Sattler M; Versées W; Ueffing M; Ubarretxena-Belandia I; Kortholt A; Gloeckner CJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):E4357-66. PubMed ID: 27357661
[TBL] [Abstract][Full Text] [Related]
13. Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain.
Piccoli G; Onofri F; Cirnaru MD; Kaiser CJ; Jagtap P; Kastenmüller A; Pischedda F; Marte A; von Zweydorf F; Vogt A; Giesert F; Pan L; Antonucci F; Kiel C; Zhang M; Weinkauf S; Sattler M; Sala C; Matteoli M; Ueffing M; Gloeckner CJ
Mol Cell Biol; 2014 Jun; 34(12):2147-61. PubMed ID: 24687852
[TBL] [Abstract][Full Text] [Related]
14. Kinase Domain Is a Dynamic Hub for Driving LRRK2 Allostery.
Taylor SS; Kaila-Sharma P; Weng JH; Aoto P; Schmidt SH; Knapp S; Mathea S; Herberg FW
Front Mol Neurosci; 2020; 13():538219. PubMed ID: 33122997
[TBL] [Abstract][Full Text] [Related]
15. The role of (auto)-phosphorylation in the complex activation mechanism of LRRK2.
Athanasopoulos PS; Heumann R; Kortholt A
Biol Chem; 2018 Jun; 399(7):643-647. PubMed ID: 29537215
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.
Vancraenenbroeck R; Lobbestael E; Weeks SD; Strelkov SV; Baekelandt V; Taymans JM; De Maeyer M
Biochim Biophys Acta; 2012 Mar; 1824(3):450-60. PubMed ID: 22251894
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional in silico analysis of LRRK2 missense substitutions.
Cardona F; Tormos-Pérez M; Pérez-Tur J
Mol Biol Rep; 2014; 41(4):2529-42. PubMed ID: 24488318
[TBL] [Abstract][Full Text] [Related]
18. P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.
Kalogeropulou AF; Zhao J; Bolliger MF; Memou A; Narasimha S; Molitor TP; Wilson WH; Rideout HJ; Nichols RJ
Biochem J; 2018 Apr; 475(7):1271-1293. PubMed ID: 29519959
[TBL] [Abstract][Full Text] [Related]
19. The Roc-COR tandem domain of leucine-rich repeat kinase 2 forms dimers and exhibits conventional Ras-like GTPase properties.
Mills RD; Liang LY; Lio DS; Mok YF; Mulhern TD; Cao G; Griffin M; Kenche VB; Culvenor JG; Cheng HC
J Neurochem; 2018 Nov; 147(3):409-428. PubMed ID: 30091236
[TBL] [Abstract][Full Text] [Related]
20. Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2.
Schmidt SH; Weng JH; Aoto PC; Boassa D; Mathea S; Silletti S; Hu J; Wallbott M; Komives EA; Knapp S; Herberg FW; Taylor SS
Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34088839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
